Rachel Kenneil

I work on antibody assay development for Nipah, MERS, and enterovirus vaccine projects at Oxford University. Our aim is to develop robust assays which can be used for measuring immune responses potentially associated with protection after vaccination. These assays are used in-house for Oxford-based clinical trials, or transferred to collaborating laboratories in the UK or overseas.

I have 15 years’ experience working on immunoassays, at all stages from initial development through to technical transfer and validation. The purpose of the immunoassays has ranged from assessment of vaccine responses in humans and animals, to characterisation and release of lentiviral vectors and T cell therapy products, with a brief excursion into lateral flow tests for drugs of abuse. My MRes and PhD in Infectious Disease are from Edinburgh University and Ludwig Maximilian University of Munich/Neuchâtel University respectively.